Posts

Showing posts with the label Nasal Drug Delivery Technology Market

Nasal Drug Delivery Technology Market: Over-The-Counter Nasal Drugs

  Nasal Drug Delivery Technology Market  by Dosage Form (Nasal Drops, Sprays, Powder, Gel), System (Multidose, Unit Dose, BI-Dose), Therapeutic Applications (Rhinitis, Congestion, Vaccinations), End User (Hospitals, Homecare) – Global Forecast to 2021″ published by MarketsandMarkets™, the global nasal drug delivery technology market is projected to reach USD 64.20 Billion by 2021 from USD 44.00 Billion in 2016, at a CAGR of 6.5% during the forecast period. Don’t miss out on business opportunities in Nasal Drug Delivery Technology Market. Speak to our analyst and gain crucial industry insights that will help your business grow:  https://www.marketsandmarkets.com/speaktoanalyst.asp?id=192818058 Increasing patient preference for nasal drug delivery because of easy administration & better efficacy and growing adoption of self-administration practices are some of the major factors driving the growth of the nasal drug delivery technology market. Furthermore, growth among ov...

Growth in Therapeutic Applications (Rhinitis, Congestion, Vaccinations) of Nasal Drug Delivery Technology Market

Image
Global nasal drug delivery technology market  is projected to reach  USD 64.20 billion by 2021 from USD 44.00 billion in 2016 , at a  CAGR of 6.5% . Increasing patient preference for nasal drug delivery as a result of easy administration & better efficacy and growing adoption of self-administration practices are some of the major factors driving the growth of the nasal drug delivery technology market. Intranasal drug delivery is one of the most preferred drug delivery routes among patients as well as healthcare providers. Download PDF Brochure @  https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=192818058 Increasing patient preference for nasal drug delivery as a result of easy administration and better efficacy Intranasal drug delivery is one of the most preferred drug delivery routes among patients as well as healthcare providers. This can majorly be attributed to the non-invasive nature of this route of delivery and the fact that drug absor...

Global Nasal Drug Delivery Technology Market | Market Dynamics and Growth Analysis 2016 - 2021

Increasing patient preference for nasal drug delivery as a result of easy administration & better efficacy and growing adoption of self-administration practices are some of the major factors driving the growth of the  nasal drug delivery technology market . Intranasal drug delivery is one of the most preferred drug delivery routes among patients as well as healthcare providers. This can be majorly attributed to the non-invasive nature of this route of delivery and the fact that drug absorbability is higher through the nasal route. The  global nasal drug delivery technology market  is projected to reach $64.20 billion by 2021 from $44.00 billion in 2016, at a CAGR of 6.5% during the forecast period. Market Dynamics  + Market Drivers + Increasing Patient Preference for Nasal Drug Delivery as A Result of Easy Administration and Better Efficacy + Growing Adoption of Self-Administration Practices Download PDF BROCHURE –  https://www.marketsandmarket...

Nasal Drug Delivery Technology Market worth 64.20 Billion USD by 2021

According to the new market research report " Nasal Drug Delivery Technology Market by Dosage Form (Nasal Drops, Sprays, Powder, Gel), System (Multidose, Unit Dose, BI-Dose), Therapeutic Applications (Rhinitis, Congestion, Vaccinations), End User (Hospitals, Homecare) - Global Forecast to 2021 " published by MarketsandMarkets™, the global nasal drug delivery technology market is projected to reach USD 64.20 Billion by 2021 from USD 44.00 Billion in 2016, at a CAGR of 6.5% during the forecast period. Don’t miss out on business opportunities in  Nasal Drug Delivery Technology Market . Speak to our analyst and gain crucial industry insights that will help your business grow:  https://www.marketsandmarkets.com/speaktoanalyst.asp?id=192818058 Increasing patient preference for nasal drug delivery because of easy administration & better efficacy and growing adoption of self-administration practices are some of the major factors driving the growth of the nasal drug delive...

Nasal Drug Delivery Technology Market to Witness Huge Growth from 2016-2021 and Focusing on Top Players are Merck & Co., Inc, Novartis AG, Johnson& Johnson Services, Inc, Pfizer, Inc, AstraZeneca Plc, Aptar Group, and GlaxoSmithKline plc

According to the new market research report “ Nasal Drug Delivery Technology Market by Dosage Form (Nasal Drops, Sprays, Powder, Gel), System (Multidose, Unit Dose, BI-Dose), Therapeutic Applications (Rhinitis, Congestion, Vaccinations), End User (Hospitals, Homecare) - Global Forecast to 2021 " published by MarketsandMarkets™, The global nasal drug delivery technology market is projected to reach USD 64.20 Billion by 2021 from USD 44.00 Billion in 2016, at a CAGR of 6.5% during the forecast period. Don’t miss out on business opportunities in Nasal Drug Delivery Technology Market. Speak to our analyst and gain crucial industry insights that will help your business grow:    https://www.marketsandmarkets.com/speaktoanalyst.asp?id=192818058 Increasing patient preference for nasal drug delivery because of easy administration & better efficacy and growing adoption of self-administration practices are some of the major factors driving the gr...

Nasal Drug Delivery Technology Market | Key Players - Merck & Co., Inc. (U.S.), Novartis AG (Switzerland), Johnson& Johnson Services, Inc. (U.S.), Pfizer, Inc. (U.S.)

Image
 Increasing patient preference for nasal drug delivery as a result of easy administration & better efficacy and growing adoption of self-administration practices are some of the major factors driving the growth of the nasal drug delivery technology market. Furthermore, growth among over-the-counter nasal drugs and increasing focus on alternative routes of drug delivery such as nasal drug delivery offer significant growth opportunities for player operating in the market. On the other hand, complications associated with the overuse of nasal sprays may restraint the growth of the nasal drug delivery technology market. The  nasal drug delivery technology market  is segmented based on dosage form, therapeutic application, end user, system, container, and region. On the basis of system, the market is segmented into multi-dose systems, bi-dose systems, and unit-dose systems. In 2016, the multi-dose drug delivery systems segment is expected to account for the larges...

Nasal Drug Delivery Technology Market worth 64.20 Billion USD by 2021

According to the new market research report  “ Nasal Drug Delivery Technology Market  by Dosage Form (Nasal Drops, Sprays, Powder, Gel), System (Multidose, Unit Dose, BI-Dose), Therapeutic Applications (Rhinitis, Congestion, Vaccinations), End User (Hospitals, Homecare) – Global Forecast to 2021″  published by MarketsandMarkets™, the global nasal drug delivery technology market is projected to reach USD 64.20 Billion by 2021 from USD 44.00 Billion in 2016, at a CAGR of 6.5% during the forecast period. Don’t miss out on business opportunities in  Nasal Drug Delivery Technology Market . Speak to our analyst and gain crucial industry insights that will help your business grow:  https://www.marketsandmarkets.com/speaktoanalyst.asp?id=192818058 Increasing patient preference for nasal drug delivery because of easy administration & better efficacy and growing adoption of self-administration practices are some of the major factors driving the growth of the nas...

Nasal Drug Delivery Technology Market worth 64.20 Billion USD

Image
Nasal Drug Delivery Technology Market by Dosage Form (Nasal Drops, Sprays, Powder, Gel), System (Multidose, Unit Dose, BI-Dose), Therapeutic Applications (Rhinitis, Congestion, Vaccinations), End User (Hospitals, Homecare) - Global Forecast to 2021. The global nasal drug delivery technology market is projected to reach USD 64.20 Billion by 2021 from USD 44.00 Billion in 2016, at a CAGR of 6.5% during the forecast period. This market is segmented based on dosage form, therapeutic application, end user, system, container, and region. The nasal drug delivery technology market is expected to witness significant growth in the coming years, due to the high demand and adoption of OTC products. Various pharmaceutical companies are focusing on the development of OTC drugs. This is expected to create growth opportunities for players offering nasal drugs, especially nasal sprays and drops which are majorly sold as generic OTC medicines. North America is projected to dominate the market i...